Page 284 - DAS_Rehberi

Kaynaklar 263

14. Christenson PR, Li M, Rowden G, et al. A field-deployable diagnostic assay for the visual detection of
misfolded prions. Sci Rep. 2022;12(1):12246.
15. Food safety. (19 May 2022 updated).https://www.who.int/news-room/fact-sheets/detail/food-safety, Erişim
Tarihi: 05.07.2024)
16. Leemans, M. Prion diseases. Anaesthesia and Intensive Care Medicine, 2020,23: 56-59.
17. Liberski, PP., Ritchie, DL., Sikorska, B. Prion diseases. Neurobiology of Brain Disorders: Biological Basis
of Neurological and Psychiatric Disorders, Second Edition, Elsevier. 2023; 361–378.
18. Napper S, Schatzl HM. Vaccines for prion diseases: a realistic goal?. Cell Tissue Res. 2023;392(1):367-
392.
19. Slow Viruses & Prions.In: Levinson W, Chin-Hong P, Joyce EA, Nussbaum J, Schwartz B.eds. Review of
Medical Microbiology & Immunology: A Guide to Clinical Infectious Diseases, 16e. McGraw Hill; 2020.
(Erişim Tarihi: 05.07.2024)
20. Prion Diseases. Public Health Agency of Canada.https://www.canada.ca/en/public-health/services/diseas-
es/prion-diseases.html, Erişim Tarihi: 05.07.2024)
21. Prion Diseases. Johns Hopkins Medicine. (https://www.hopkinsmedicine.org/health/conditions-and-dis-
eases/prion-diseases, Erişim Tarihi: 05.07.2024)
22. Prion Infection Control. Memory and Aging Center. (https://memory.ucsf.edu/dementia/rapidly-progres-
sive-dementias/prion-infection-control, Erişim Tarihi: 05.07.2024)
23. Sakaguchi S. Prion Pathogenesis Revealed in a Series of the Special Issues “Prions and Prion Diseases”. Int
J Mol Sci. 2022;23(12):6490.
24. Seto EP, Hirsch AL, Schubert WW, Chandramowlishwaran P, Chernoff YO. Heat inactivation of stable
proteinaceous particles for future sample return mission architecture. Front Microbiol. 2022;13:911091.
25. Transmissible Spongiform Encephalopathies.https://www.who.int/teams/health-product-policy-and-stan-
dards/standards-and-specifications/transmissible-spongiform-encephalopathies, Erişim Tarihi: 05.07.2024)
26. Tsou A, Chen PJ, Tsai KW, Hu WC, Lu KC. THαβ Immunological Pathway as Protective Immune Re-
sponse against Prion Diseases: An Insight for Prion Infection Therapy. Viruses. 2022;14(2):408.
27. Zhao, Y., Gong, X., Jin, S., Luo, L. Research progress on prion protein structure and molecular mecha-
nism of pathogenicity. In Second International Conference on Biological Engineering and Medical Science,
2022:12611; 540-546.
28. Infection Control for CJD. (https://www.cdc.gov/creutzfeldt-jakob/hcp/infection-control, Erişim Tarihi:
05.07.2024)

ANNE SÜTÜ VE MAMA HAZIRLIĞINDA DAS UYGULAMALARI
1. Centers for Disease Control and Prevention. Infant Formula Preparation and Storage (https://www.cdc.gov/
nutrition/InfantandToddlerNutrition/formula-feeding/infant-formula-preparation-and-storage.html Erişim
tarihi: 09.06.2024 ).
2. Eglash A, Simon L; Academy of Breastfeeding Medicine. ABM Clinical Protocol #8: Human Milk Storage
Information for Home Use for Full-Term Infants, Revised 2017 [published correction appears in Breastfeed
Med. 2018 Jul/Aug;13(6):459.
3. T.C. Sağlık Bakanlığı. Halk Sağlığı Genel Müdürlüğü. Anne Sütü Broşür.2024. (https://hsgm.saglik.gov.tr/
depo/birimler/cocuk-ergen-sagligi-db/Dokumanlar/Afisler-Brosurler/anne_sutu_brosur.pdf . Erişim tarihi:
09.06.2024)
4. Bilgen H, Kültürsay N, Türkyılmaz C. Turkish Neonatal Society guideline on nutrition of the healthy term
newborn. Turk Pediatri Ars 2018; 53(Suppl 1): S128-S137

TIBBİ CİHAZ YÖNETMELİĞİ
1. https://www.mevzuat.gov.tr/mevzuat?MevzuatNo=38657&MevzuatTur=7&MevzuatTertip=5